Evid Based Med doi:10.1136/eb-2012-101121
  • Practice guideline
  • Systematic review

Guidelines on glucose self-monitoring in non-insulin users are not evidence-based

  1. Julienne K Kirk
  1. Department of Family & Community Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA
  1. Correspondence to Julienne K Kirk
    Department of Family & Community Medicine, Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157, USA, jkirk{at}

Commentary on:


There is controversy over the use of self-monitoring blood glucose (SMBG) in patients with type 2 diabetes mellitus (T2DM) not taking insulin. SMBG for patients taking insulin is supported by necessity to closely monitor glucose and potential fluctuations. Many individuals with T2DM use SMBG to guide treatment decisions while others use SMBG to fulfil clinician recommendations to check blood glucose levels. Since many patients with T2DM are not always prone to hypoglycaemia, the utility of the frequent testing is debatable. In addition, the financial implications of SMBG can be tremendous, and SMBG may reduce quality of life. Third party payers will not always support SMBG with high frequency testing in T2DM non-insulin users. Aakre and colleagues examine SMBG in non-insulin T2DM with regard to recommendations put forth by clinical …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBM.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article